Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
It's important to learn from history: Jim Cramer on which stocks perform best after rate cuts start
Mad Money' host Jim Cramer looks at what stocks tend to perform well once the Fed starts cutting rates. Republicans assess potential fallout for Trump from North Carolina bombshell Nasa makes discovery ‘as important as gravity’ about Earth Florida,
Jim Cramer says the Fed is likely to make a rate cut next week
CNBC’s Jim Cramer on Monday suggested the Federal Reserve will make a much-anticipated rate cut at its meeting next week.
Jim Cramer explains why he's not worried about the Fed's aggressive rate cut
CNBC’s Jim Cramer attempted to put to bed any fears on Wall Street that Wednesday’s 50 basis point rate cut was a negative move for the market.
Cramer says to ‘sit on your hands' until the Fed makes a rate cut decision
CNBC’s Jim Cramer on Monday told investors not to make any moves until the Federal Reserve announces interest rate cuts.
Jim Cramer talks which stocks do well when the Fed starts cutting rates
Mad Money' host Jim Cramer looks at what stocks tend to perform well once the Fed starts cutting rates.
2h
Jim Cramer Thinks Southern (SO) is a ‘Baby Growth Story’
Stocks to Watch in September. Since Southern Co (NYSE:SO) ranks 7th on the list, it deserves a deeper look. Jim Cramer said ...
12h
Cramer's Lightning Round: Viking is a buy
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
2h
on MSN
Jim Cramer Says GameStop’s (GME) Core Business ‘Doesn’t Matter Anymore’
Stocks to Watch in September. Since GameStop Corp (NYSE:GME) ranks 9th on the list, it deserves a deeper look. Jim Cramer ...
3h
Jim Cramer: Viking Therapeutics Has 'Many Ships Coming In'
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
14d
Jim Cramer says investors should be ‘playing the waiting game' until the Fed makes a move
CNBC’s Jim Cramer told investors not to make any major moves and listed impatient mistakes that he thinks many are making.
8h
on MSN
Jim Cramer on Nextracker Inc. (NXT): ‘I Know It’s Been A Big Disappointment For Club Members, But You’ve Got To Stick With It’
We recently compiled a list of the Jim Cramer’s Top 12 Must-Watch Stocks. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback